Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:2284–309.
CAS PubMed Article Google Scholar
Le TT, Lim V, Ibrahim R, Teo MT, Bryant J, Ang B, et al. The remodelling index risk stratifies patients with hypertensive left ventricular hypertrophy. Eur Heart J Cardiovasc Imaging. 2021;22:670–9.
Hoang K, Zhao Y, Gardin JM, Carnethon M, Mukamal K, Yanez D, et al. LV mass as a predictor of CVD events in older adults with and without metabolic syndrome and diabetes. JACC Cardiovasc Imaging. 2015;8:1007–15.
PubMed PubMed Central Article Google Scholar
Tripepi G, D’Arrigo G, Mallamaci F, London G, Tangri N, Hsu JY, et al. Prognostic values of left ventricular mass index in chronic kidney disease patients. Nephrol Dial Transpl. 2021;36:665–72.
Zhang H, Hu L, Wei XJ. Prognostic value of left ventricular hypertrophy in hypertensive patients: a meta-analysis of electrocardiographic studies. Clin Hypertens. 2020;22:254–60.
Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–6.
CAS PubMed Article Google Scholar
Pierdomenico SD, Lapenna D, Cuccurullo F. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension. Am J Hypertens. 2008;21:464–70.
Sheng Y, Li M, Xu M, Zhang Y, Xu J, Huang Y, et al. Left ventricular and atrial remodelling in hypertensive patients using thresholds from international guidelines and EMINCA data. Eur Heart J Cardiovasc Imaging. 2022;23:166–74.
Ikejder Y, Sebbani M, Hendy I, Khramz M, Khatouri A, Bendriss L. Impact of arterial hypertension on left atrial size and function. Biomed Res Int. 2020;2020:2587530.
Lilja-Cyron A, Bang CN, Gerdts E, Larstorp AC, Kjeldsen SE, Julius S, et al. Aortic root dilatation in hypertensive patients with left ventricular hypertrophy-application of a new multivariate predictive model. The Life Study. Rev Cardiovasc Med. 2022;23:95.
Nakanishi K, Daimon M, Yoshida Y, Ishiwata J, Sawada N, Hirokawa M, et al. Blood pressure categorization and subclinical left ventricular dysfunction in antihypertensive medication-naive subjects. ESC Heart Fail. 2022;9:1766–74.
PubMed PubMed Central Article Google Scholar
Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation. 1997;95:1464–70.
CAS PubMed Article Google Scholar
Sivén SS, Niiranen TJ, Langén VL, Puukka PJ, Kantola IM, Jula AM. Home versus office blood pressure: longitudinal relations with left ventricular hypertrophy: the Finn-Home study. J Hypertens. 2017;35:266–71.
PubMed Article CAS Google Scholar
Nwabuo CC, Vasan RS. Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy. Curr Hypertens Rep. 2020;22:11.
Cosenso-Martin LN, Vaz-de-Melo RO, Pereira LR, Cesarino CB, Yugar-Toledo JC, Cipullo JP, et al. Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study. Eur J Med Res. 2015;20:74.
PubMed PubMed Central Article CAS Google Scholar
Pi M, Ye R, Han X, Armstrong B, Liu X, Chen Y, et al. Cardiovascular interactions between fibroblast growth factor-23 and angiotensin ii. Sci Rep. 2018;8:12398.
PubMed PubMed Central Article CAS Google Scholar
Song WH, Lin YH, Sun K, Zhang YH, Song Y, Hou LB, et al. A functional variant in the coding region of CAMTA2 is associated with left ventricular hypertrophy by affecting the activation of Nkx2.5-dependent transcription. J Hypertens. 2016;34:942–9.
CAS PubMed Article Google Scholar
Ahmad FS, Cai X, Kunkel K, Ricardo AC, Lash JP, Raj DS, et al. CRIC Study Investigators. Racial/ethnic differences in left ventricular structure and function in chronic kidney disease: The Chronic Renal Insufficiency Cohort. Am J Hypertens. 2017;30:822–9.
PubMed PubMed Central Article Google Scholar
Lucà F, Abrignani MG, Parrini I, Di Fusco SA, Giubilato S, Rao CM, et al. Update on management of cardiovascular diseases in women. J Clin Med. 2022;11:1176.
PubMed PubMed Central Article CAS Google Scholar
Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002;23:90–119.
CAS PubMed Article Google Scholar
Sabbatini AR, Kararigas G. Estrogen-related mechanisms in sex differences of hypertension and target organ damage. Biol Sex Differ. 2020;11:31.
CAS PubMed PubMed Central Article Google Scholar
Li S, Gupte AA. The role of estrogen in cardiac metabolism and diastolic function. Methodist Debakey Cardiovasc J. 2017;13:4–8.
PubMed PubMed Central Article Google Scholar
Pedersen LR, Kristensen AMD, Petersen SS, Vaduganathan M, Bhatt DL, Juel J, et al. Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography. J Clin Hypertens. 2020;22:1647–58.
Vasan RS, Song RJ, Xanthakis V, Beiser A, DeCarli C, Mitchell GF, et al. Hypertension-mediated organ damage prevalence, correlates, and prognosis in the community. Hypertension. 2022;79:505–15.
CAS PubMed Article Google Scholar
Tanaka K, Tanaka F, Onoda T, Tanno K, Ohsawa M, Sakata K, et al. Iwate-Kenco Study Group Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population. Am J Hypertens. 2018;31:895–901.
CAS PubMed Article Google Scholar
Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, et al. Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH). Eur Heart J Cardiovasc Imaging. 2017;18:945–60.
Cuspidi C, Rescaldani M, Sala C, Negri F, Grassi G, Mancia G. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review. J Hypertens. 2012;30:2066–73.
CAS PubMed Article Google Scholar
dos Santos JPA, Ribeiro ALP, Andrade-Junior D, Marcolino MS. Prevalence of electrocardiographic abnormalities in primary care patients according to sex and age group. A retrospective observational study. Sao Paulo Med J. 2018;136:20–8.
Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012;26:343–9.
CAS PubMed Article Google Scholar
Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008;51:1109–14.
CAS PubMed Article Google Scholar
de Simone G, Devereux RB, Izzo R, Girfoglio D, Lee ET, Howard BV, et al. Lack of reduction of left ventricular mass in treated hypertension: the Strong Heart Study. J Am Heart Assoc. 2013;2:e000144.
PubMed PubMed Central Article Google Scholar
Gerdts E, Izzo R, Mancusi C, Losi MA, Manzi MV, Canciello G, et al. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). Int J Cardiol. 2018;258:257–61.
Cai A, Liu L, Zhou D, Tang S, Zhou Y, Feng Y. Influences of achieved SBP on age and sex-related left ventricular structural alteration in community hypertensive populations. J Hypertens. 2022;40:1170–8.
CAS PubMed Article Google Scholar
de Simone G, Mancusi C, Izzo R, Losi MA, Ferrara LA. Obesity and hypertensive heart disease: focus on body composition and sex difference. Diabetol Metab Syndr. 2016;8:79.
PubMed PubMed Central Article CAS Google Scholar
Nunez E, Arnett DK, Benjamin EJ, Oakes JM, Liebson PR, Skelton TN. Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women. Am J Cardiol. 2004;94:1383–90.
Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, et al. Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy. Hypertension 2008;52:100–6.
CAS PubMed Article Google Scholar
Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2008;51:1109–14.
CAS PubMed Article Google Scholar
Lønnebakken MT, Izzo R, Mancusi C, Gerdts E, Losi MA, Canciello G, et al. Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network. Am Heart Assoc. 2017;6:e004152.
Voorhees AP, Han HC. Biomechanics of cardiac function. Compr Physiol. 2016;5:1623–44.
留言 (0)